Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.
Jessica L. Kerr, PharmD, CDE
Advertisement
Articles by Jessica L. Kerr, PharmD, CDE
This Continuing Education activity is supported by an educational grant from Novo Nordisk.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
2
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
3
Halfway There Is Nowhere
4
Combined Food Policies, Including Labeling and Advertising Bans, Plausibly Reduce Childhood Obesity
5